Market Tracker

09/01 1:05pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.48
Data as of Aug 29
 -0.01 / -0.29%
Today’s Change
2.81
Today|||52-Week Range
5.50
-13.43%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close3.49
Today’s open3.48
Day’s range3.42 - 3.51
Volume45,701
Average volume (3 months)115,169
Market cap$78.9M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+21.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...+0.41+7.37%
BOTABiota Pharmaceutical...-0.04-1.71%
MSTXMast Therapeutics In...+0.02+2.46%
GLMDGalmed Pharmaceutica...-0.01-0.15%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 17, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts